Sanofi And Joslin Team Up On Diabetes Discovery
This article was originally published in The Pink Sheet Daily
Sanofi continues to look for new, innovative ways to diversify its diabetes portfolio; its latest endeavor is a discovery collaboration with Harvard Medical School’s Joslin Diabetes Center.
You may also be interested in...
Walgreens’ deal to acquire Alliance Boots vastly expands its international presence but got a chilly reception on Wall Street.
Merck announced March 15 that it plans to invest $90 million over the next seven years in a nonprofit biomedical research center in San Diego dubbed the California Institute for Biomedical Research, or Calibr.
The collaboration is the third in its localized Centers for Therapeutic Innovation project, intended to nudge academics toward commercial projects.